Mission: to provide clients expert and in depth scientific, patent, and market analysis of innovational high technology properties. Objective: to prepare clear, concise, and sound third party analytic reviews of emerging biological, biomedical, medical device, chemical, and electronic technologies. Process: our method of data intake, review, and analysis culminates in the generation of reports, authored by members of our task-selected and -oriented expert panels. Pb2Au’s assessment documents enable innovators, small startup companies included, to present even the most esoteric and complex high-technology properties to potential investors in a thoroughly reliable and efficacious manner at several levels of understanding. Our reports enable investment entities to conduct sound, solidly based risk (or cost) / benefit analyses of complex, high tech properties.